Home › Funds › Point72 Asset Management › ANRO
Point72 Asset Management position in ANRO
ALTO NEUROSCIENCE INC · Health Care
Latest position (Q2 2026)502.95K sh
Reported value held$13.27M
Portfolio Weight0.02%
First reportedQ1 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 1.12M | $17.27M | New |
| Q2 2024 | 1.05M | $11.22M | Reduce |
| Q3 2024 | 977.69K | $11.18M | Reduce |
| Q4 2024 | 1.69M | $7.16M | Add |
| Q1 2025 | 1.24M | $2.68M | Reduce |
| Q2 2025 | 1.33M | $2.93M | Add |
| Q3 2025 | 1.33M | $5.36M | Hold |
| Q4 2025 | 1.61M | $28.60M | Add |
| Q1 2026 | 503.09K | $11.31M | Reduce |
| Q2 2026 | 502.95K | $13.27M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANRO
- BlackRock Inc 2.12M sh · $55.97M · Q2 2026
- Franklin Resources 1.01M sh · $26.74M · Q2 2026
- Vanguard Group 1.37M sh · $24.31M · Q4 2025
- Geode Capital Management 678.20K sh · $17.90M · Q2 2026
- Northern Trust Corp 632.70K sh · $16.70M · Q2 2026
- Millennium Management 558.32K sh · $14.73M · Q2 2026
- Goldman Sachs Group 236.83K sh · $6.25M · Q2 2026
- Marshall Wace 225.50K sh · $5.95M · Q2 2026
- Two Sigma Investments 147.30K sh · $3.89M · Q2 2026
- Alkeon Capital Management 102.10K sh · $2.69M · Q2 2026
- Charles Schwab Investment Management 80.58K sh · $2.13M · Q2 2026